Experienced in Maffucci Syndrome

Antonino C. Romeo

Department Of Head And Neck, 
Rome, IT 
Experienced in Maffucci Syndrome
Department Of Head And Neck, 
Rome, IT 
OverviewLocationsClinical Research

Overview

Antonino Romeo practices in Rome, Italy. Mr. Romeo is rated as an Experienced expert by MediFind in the treatment of Maffucci Syndrome. His top areas of expertise are Aicardi Syndrome, Mesothelioma, Squamous Cell Skin Carcinoma, and Lennox-Gastaut Syndrome (LGS).

His clinical research consists of co-authoring 92 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Maffucci Syndrome.

Gender
Male

Locations

Department Of Head And Neck, Rome, 00168, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating HDR Brachytherapy: Single Institution Feasibility Study
Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating HDR Brachytherapy: Single Institution Feasibility Study
Enrollment Status: Terminated
Publish Date: May 30, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.
Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.
Enrollment Status: Completed
Publish Date: July 21, 2017
Intervention Type: Drug, Radiation
Study Phase: Phase 2
View 1 Less Clinical Trial

92 Total Publications

Correction: Bedeschi et al. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385.
Correction: Bedeschi et al. Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. Pharmaceuticals 2025, 18, 385.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Romeo's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile